BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35487087)

  • 1. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.
    Srikanth M; Rasool M
    Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions.
    Li Y; Cui H; Li S; Li X; Guo H; Nandakumar KS; Li Z
    Int Immunopharmacol; 2023 Jan; 114():109585. PubMed ID: 36527884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice.
    Lo HY; Li CC; Cheng HM; Liu IC; Ho TY; Hsiang CY
    Food Chem Toxicol; 2019 Jul; 129():365-375. PubMed ID: 31054998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes.
    Moos S; Mohebiany AN; Waisman A; Kurschus FC
    J Invest Dermatol; 2019 May; 139(5):1110-1117. PubMed ID: 30684554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model.
    Tang J; Liu C; Liu S; Zhou X; Lu J; Li M; Zhu L
    Eur J Pharmacol; 2022 Oct; 933():175276. PubMed ID: 36130639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosmarinic acid ameliorated psoriatic skin inflammation in mice through the novel inhibition of the interleukin-17A/interleukin-17A receptor interaction.
    Ho TY; Lo HY; Liu IC; Huang SL; Hsiang CY
    Food Funct; 2022 Jun; 13(12):6802-6812. PubMed ID: 35674182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
    Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
    Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis.
    Morelli M; Scarponi C; Mercurio L; Facchiano F; Pallotta S; Madonna S; Girolomoni G; Albanesi C
    J Immunol Res; 2018; 2018():7897263. PubMed ID: 30581877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis.
    Samarpita S; Ganesan R; Rasool M
    Toxicol Appl Pharmacol; 2020 Mar; 391():114917. PubMed ID: 32044269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
    Zhao K; Pu S; Sun L; Zhou D
    Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A.
    Zhang L; Ma X; Shi R; Zhang L; Zhao R; Duan R; Qin Y; Gao S; Li X; Duan J; Li J
    Br J Pharmacol; 2023 Mar; 180(5):628-646. PubMed ID: 36355777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation.
    Roy T; Banang-Mbeumi S; Boateng ST; Ruiz EM; Chamcheu RN; Kang L; King JA; Walker AL; Nagalo BM; Kousoulas KG; Esnault S; Huang S; Chamcheu JC
    Front Immunol; 2022; 13():1075804. PubMed ID: 36741386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The small molecule rhodomyrtone suppresses TNF-α and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis.
    Chorachoo J; Lambert S; Furnholm T; Roberts L; Reingold L; Auepemkiate S; Voravuthikunchai SP; Johnston A
    PLoS One; 2018; 13(10):e0205340. PubMed ID: 30321197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
    Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
    Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
    Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
    Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
    Deepak HB; Prince SE; Deshpande P
    Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-hydroxytryptophan attenuates imiquimod-induced psoriasiform dermatitis probably through inhibition of IL-17A production and keratinocyte activation.
    Hsu PY; Yang HJ; Yang TH; Su CC
    Exp Dermatol; 2018 Nov; 27(11):1273-1279. PubMed ID: 30221419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.